Philip J. Mease,
Nathan Wei,
Edward J. Fudman,
Alan J. Kivitz,
Joy Schechtman,
Robert G. Trapp,
Kathryn F. Hobbs,
Maria Greenwald,
Antony Hou,
Stephen A. Bookbinder,
Galen E. Graham,
Craig W. Wiesenhutter,
Larry Willis,
Eric M. Ruderman,
Joseph Z. Forstot,
Michael J. Maricic,
Kathryn H. Dao,
Charles H. Pritchard,
Darrell N. Fiske,
Francis X. Burch,
H. Malin Prupas,
Pervin Anklesaria,
Alison E. Heald,
- Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study. Mease, P.J., Wei, N., Fudman, E.J., Kivitz, A.J., Schechtman, J., Trapp, R.G., Hobbs, K.F., Greenwald, M., Hou, A., Bookbinder, S.A., Graham, G.E., Wiesenhutter, C.W., Willis, L., Ruderman, E.M., Forstot, J.Z., Maricic, M.J., Dao, K.H., Pritchard, C.H., Fiske, D.N., Burch, F.X., Prupas, H.M., Anklesaria, P., Heald, A.E. J. Rheumatol. (2010)